Y. Zuo

Combination therapy with Pretarget CC49 radioimmunotherapy and gemcitabine prolongs tumor doubling time in a murine xenograft model of colon cancer more effectively than either monotherapy.

K. Auditore-Hargreaves, Yukang Lin, E. Dearstyne, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Single-chain Fv-streptavidin substantially improved therapeutic index in multistep targeting directed at disialoganglioside GD2.

S. Larson, N. Cheung, P. Zanzonico, 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

A tetravalent single-chain antibody-streptavidin fusion protein for pretargeted lymphoma therapy.

Y. Lin, Y Lin, J Schultz, 2000, Cancer research.